-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Vivani Medical (NASDAQ:VANI) Stock Price Down 2.5%
Vivani Medical (NASDAQ:VANI) Stock Price Down 2.5%
Vivani Medical, Inc. (NASDAQ:VANI – Get Rating) was down 2.5% on Tuesday . The stock traded as low as $0.86 and last traded at $0.91. Approximately 119,948 shares changed hands during mid-day trading, an increase of 4% from the average daily volume of 115,268 shares. The stock had previously closed at $0.93.
Analyst Upgrades and Downgrades
Separately, ThinkEquity started coverage on Vivani Medical in a report on Monday, December 5th. They issued a "buy" rating and a $7.00 price target for the company.
Get Vivani Medical alerts:Vivani Medical Stock Down 2.5 %
The firm has a fifty day moving average price of $1.52.
Institutional Investors Weigh In On Vivani Medical
A number of institutional investors and hedge funds have recently modified their holdings of the company. State Street Corp acquired a new stake in shares of Vivani Medical during the third quarter worth about $63,000. Vanguard Group Inc. acquired a new stake in shares of Vivani Medical during the third quarter worth about $682,000. Prelude Capital Management LLC acquired a new stake in shares of Vivani Medical during the third quarter worth about $25,000. BlackRock Inc. acquired a new stake in shares of Vivani Medical during the third quarter worth about $734,000. Finally, Commonwealth Equity Services LLC acquired a new stake in shares of Vivani Medical during the third quarter worth about $822,000.Vivani Medical Company Profile
(Get Rating)
Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.
Featured Stories
- Get a free copy of the StockNews.com research report on Vivani Medical (VANI)
- 3 Industrial Stocks to Help Build Your 2023 Watchlist
- The Institutions Choose CarMax Over Carvana, Should You?
- Heatmap in Trading: How to Learn What Market Depth Hides
- Micron Technology Sees Chip Recovery by the End of 2023
- Three Healthcare Penny Stocks to Watch In The New Year
Receive News & Ratings for Vivani Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivani Medical and related companies with MarketBeat.com's FREE daily email newsletter.
Vivani Medical, Inc. (NASDAQ:VANI – Get Rating) was down 2.5% on Tuesday . The stock traded as low as $0.86 and last traded at $0.91. Approximately 119,948 shares changed hands during mid-day trading, an increase of 4% from the average daily volume of 115,268 shares. The stock had previously closed at $0.93.
維萬尼醫療公司 (NASDAQ: 凡尼 — 獲取評級) 是下降 2.5% 在星期二.該股票的交易價格低至 0.86 美元,最後交易價格為 0.91 美元。大約 119,948 股股票在日間交易期間轉手,較每日平均成交量 115,268 股增加 4%。該股票之前已收盤 0.93 美元。
Analyst Upgrades and Downgrades
分析師升級和降級
Separately, ThinkEquity started coverage on Vivani Medical in a report on Monday, December 5th. They issued a "buy" rating and a $7.00 price target for the company.
另外,思想開始覆蓋維瓦尼醫療在週一的報告中,12 月 5 日。他們為該公司發布了「買入」評級和 7.00 美元的目標價格。
Vivani Medical Stock Down 2.5 %
維萬尼醫療股票下降 2.5%
The firm has a fifty day moving average price of $1.52.
該公司的五十天移動平均價格為 1.52 美元。
Institutional Investors Weigh In On Vivani Medical
機構投資者權衡維萬尼醫療
Vivani Medical Company Profile
維萬尼醫療公司簡介
(Get Rating)
(取得評分)
Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.
Vivani Medical, Inc 是一家臨床階段公司,開發各種植入物,用於治療未滿足的高度醫療需求的慢性疾病。它致力於開發微型藥物植入物的產品組合,以提供最小波動的藥物特徵;以及可植入的視覺假肢裝置,為盲人提供有用的人工視覺。
Featured Stories
特色故事
- Get a free copy of the StockNews.com research report on Vivani Medical (VANI)
- 3 Industrial Stocks to Help Build Your 2023 Watchlist
- The Institutions Choose CarMax Over Carvana, Should You?
- Heatmap in Trading: How to Learn What Market Depth Hides
- Micron Technology Sees Chip Recovery by the End of 2023
- Three Healthcare Penny Stocks to Watch In The New Year
- 免費獲取有關薇萬尼醫療(VANI)的研究報告
- 3 種工業股票可幫助建立您的 2023 觀察列表
- 機構選擇 CarMax 而不是卡瓦娜,你應該嗎?
- 交易中的熱圖:如何了解市場深度隱藏了什麼
- 美光技術將在 2023 年底前恢復芯片
- 三個醫療保健便士股在新的一年要關注
Receive News & Ratings for Vivani Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivani Medical and related companies with MarketBeat.com's FREE daily email newsletter.
接收 Vivani 醫療日報的新聞和評分 -在下面輸入您的電子郵件地址,以通過 MarketBeat.com 的免費每日電子郵件通訊接收 Vivani Medical 及相關公司的最新新聞和分析師評級的簡要每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧